Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Xphyto Therapeutics Corp (XPHY.CN)

Xphyto Therapeutics Corp (XPHY.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 103,165
  • Shares Outstanding, K 48,663
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings -0.08 on 09/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.300 +68.46%
on 01/27/20
2.250 -2.67%
on 02/21/20
+0.810 (+58.70%)
since 01/21/20
3-Month
0.800 +173.75%
on 12/03/19
2.250 -2.67%
on 02/21/20
+1.180 (+116.83%)
since 11/21/19

Most Recent Stories

More News
Exclusive Strategic Partnership Commenced Between XPhyto Therapeutics and Elite Bavarian Brewing & Beverage Institute Weihenstephan

Vancouver, British Columbia--(Newsfile Corp. - February 18, 2020) - ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"),...

XPHY.CN : 2.190 (+3.30%)
XPHYF : 1.5800 (+6.61%)
XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market

Vancouver, British Columbia--(Newsfile Corp. - January 27, 2020) - ("XPhyto" or the "Company") is pleased to announce that the Company has signed a three year definitive supply, import and distribution...

XPHY.CN : 2.190 (+3.30%)
XPHYF : 1.5800 (+6.61%)
PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market

PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO; OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia...

XPHY.CN : 2.190 (+3.30%)
Epilepsy Treatment to Be Developed with XPhyto Therapeutics' Oral Thin Film Delivery System

Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - ("XPhyto" or the "Company") is pleased to announce that the development of Epilepsy treatment products using its proprietary oral thin...

XPHY.CN : 2.190 (+3.30%)
XPhyto Therapeutics Developing Epilepsy Treatment with Oral Thin Film Delivery System

Vancouver, British Columbia--(Newsfile Corp. - December 6, 2019) - ("XPhyto" or the "Company") is pleased to announce that the development of Epilepsy treatment products using its proprietary oral thin...

XPHY.CN : 2.190 (+3.30%)
XPhyto Therapeutics Pharmaceutical-Grade Cannabis Extraction Lab

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2019) - ("XPhyto" or the "Company") is pleased to announce that the Company's pharmaceutical grade extraction and processing laboratory (the...

XPHY.CN : 2.190 (+3.30%)
Xphyto Therapeutics Oral and Transdermal Cannabis Delivery and Dosage Systems

Vancouver, British Columbia--(Newsfile Corp. - November 12, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to provide an update on the Company's thin film...

XPHY.CN : 2.190 (+3.30%)
XPhyto Therapeutics to Present at Munich Investment Conference 08 and 09 November 2019

VANCOUVER, BC / ACCESSWIRE / November 5, 2019 / XPhyto Therapeutics Corp. (CSE:XPHY)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that it will be presenting at the International Precious...

XPHY.CN : 2.190 (+3.30%)
XPhyto Therapeutics Signs Term Sheet for German Cannabis Distribution

Vancouver, British Columbia--(Newsfile Corp. - November 4, 2019) - (CSE: XPHY) (FSE: 4XT)("XPhyto" or the "Company") is pleased to announce that it has signed a term sheet (the "Term Sheet") with a major...

XPHY.CN : 2.190 (+3.30%)
Canadian Securities Exchange Reports Strong Trading Activity, Listings Growth and Other Milestones in Third Quarter of 2019

Toronto, Ontario--(Newsfile Corp. - October 16, 2019) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced performance and operating highlights for the third quarter ("Q3 2019")...

BFGC : 0.1300 (-5.11%)
INNO : 0.0035 (-25.53%)
RVVTF : 0.0450 (-10.71%)
VYGR : 12.73 (-0.08%)
BLLG.CN : 1.550 (unch)
MGRO.CN : 0.650 (+14.04%)
BHNG.CN : 0.170 (unch)
SWIS.CN : 0.125 (-10.71%)
MGXR.CN : 0.480 (+26.32%)
RVV.CN : 0.055 (-8.33%)
WAL.CN : 0.200 (unch)
XPHY.CN : 2.190 (+3.30%)
CRUZ.CN : 0.050 (-9.09%)
NUGT.CN : 0.100 (+100.00%)
CIG.CN : 0.015 (+50.00%)
AYR-A.CN : 11.400 (-0.87%)
VC.CN : 0.100 (unch)
XCX.CN : 0.305 (unch)
QSC.CN : 0.110 (+10.00%)
CRS.CN : 1.000 (-1.96%)
BFG.CN : 0.190 (+2.70%)
PIKE.CN : 0.100 (unch)
XS.CN : 0.310 (-8.82%)
VYGR.CN : 0.310 (+3.33%)
YT.CN : 0.090 (unch)
CRC.CN : 0.030 (-25.00%)
IMCX.CN : 0.450 (unch)
WIKI.CN : 0.090 (+12.50%)

Key Turning Points

2nd Resistance Point 2.297
1st Resistance Point 2.243
Last Price 2.190
1st Support Level 2.143
2nd Support Level 2.097

See More

52-Week High 2.250
Last Price 2.190
Fibonacci 61.8% 1.669
Fibonacci 50% 1.490
Fibonacci 38.2% 1.311
52-Week Low 0.730

See More

Business Summary

XPhyto Therapeutics Corp is a Canada based cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar